Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LK.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LK.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LK.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LK.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LK.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LK.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.7.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.7.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.16.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.16.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.16.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.16.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LW.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LW.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LW.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LW.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LP.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LP.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used